Vertex Pharmaceuticals Defined Contribution Plan Expense remained flat by 0.0% to $15.78M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 20.7%, from $13.08M to $15.78M. Over 2 years (FY 2023 to FY 2025), Defined Contribution Plan Expense shows an upward trend with a 20.3% CAGR.
Changes reflect shifts in headcount, compensation levels, or adjustments to the company's retirement benefit matching policy.
The total expense recognized by the company for contributions made to employee defined contribution plans, such as 401(k...
Standard operating expense item for companies with large workforces.
is_msft_defined_contribution_plan_expense| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $43.60M | $52.30M | $63.10M |
| YoY Change | — | +20.0% | +20.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.